Previous 10 | Next 10 |
Highlighting Ocugen research and innovative technologies Featuring thought leaders in gene therapy and vaccines MALVERN, Pa., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, ...
• No safety concerns noted in ongoing clinical trial • Study timeline remains on track MALVERN, Pa., Oct. 12, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips AMTD Digital (NYSE: HKD ) stock is climbing over 18% in early trading after advancing 35% yesterday. Trading in the shares was paused twice yesterday morning due to volatility. Since no company-specific news that wo...
Vaccine maker Ocugen (NASDAQ: OCGN) has had a tumultuous past 18 months on the stock market. The company's shares soared as it sought to make good on its intentions to enter the COVID-19 vaccine space, but with the delays it has encountered in this area, investors have largely given...
MALVERN, Pa., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that the Company w...
MALVERN, Pa., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that Dr. Sha...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Tero Vesalainen / Shutterstock.com Lyft (NASDAQ: LYFT ) stock is getting a boost on Wednesday after the ride-sharing company revealed a stop to hiring in the U.S. for the rest of the year. A spokespe...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: sylv1rob1 / Shutterstock.com Apple (NASDAQ: AAPL ) stock is slipping on Wednesday after the tech company revealed plans to slow production for its iPhone line . At least, that’s one way to look...
Clinical-stage biotech Ocugen, Inc. ( NASDAQ: OCGN ) announced a licensing deal with Washington University in St. Louis, MO, on Wednesday to introduce an intranasally delivered COVID-19 vaccine in the U.S., Europe, and Japan. Ocugen ( OCGN ) shares added ~7% in t...
Ocugen’s intranasal candidate is one of the world’s most advanced intranasal COVID-19 vaccines Intranasal vaccine is designed to curb virus transmission and confer protective immunity MALVERN, Pa., Sept. 28, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen) (N...
News, Short Squeeze, Breakout and More Instantly...
• Initiated Phase 2 clinical trial MALVERN, Pa., July 25, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and va...
2024-07-11 08:45:00 ET It hasn't been a stellar year so far for biotech companies. The industry, as measured by the SPDR S&P Biotech ETF , is up just 4% since January, significantly lagging the S&P 500 's nearly 17% gain. Of course, it's not hard to find stocks that have...